WHO Framework Convention on Tobacco Control

Total Page:16

File Type:pdf, Size:1020Kb

WHO Framework Convention on Tobacco Control WHO Framework COnventiOn On Tobacco COntrOl The transcript of a Witness Seminar organized by the Wellcome Trust Centre for the History of Medicine at UCL, in collaboration with the Department of Knowledge Management and Sharing, WHO, held in Geneva, on 26 February 2010 edited by l a reynolds and e m tansey volume 43 2012 ©the trustee of the Wellcome trust, london, 2012 First published by Queen mary, University of london, 2012 the History of modern biomedicine research Group is funded by the Wellcome trust, which is a registered charity, no. 210183. iSbn 978 090223 877 0 all volumes are freely available online at www.history.qmul.ac.uk/research/modbiomed/ wellcome_witnesses/ Please cite as: reynolds l a, tansey e m. (eds) (2012) WHO Framework Convention on Tobacco Control. Wellcome Witnesses to twentieth Century medicine, vol. 43. london: Queen mary, University of london. CONTENTS illustrations and credits v abbreviations vii Witness Seminars: meetings and publications; acknowledgements E M Tansey and L A Reynolds ix introduction Virginia Berridge xxi transcript Edited by L A Reynolds and E M Tansey 1 appendix 1 Selected provisions of the Framework Convention on Tobacco Control 73 appendix 2 WHO regions 74 appendix 3 WHO FCTC, timeline, 1993–2011 75 appendix 4 World’s leading unmanufactured tobacco producing, trading, and consuming countries, 1997 79 appendix 5 Reflections on FCTC negotiations: China and Japan Dr Judith Mackay, 15 December 2011 81 references 85 biographical notes 109 Glossary 119 index 125 ILLUSTRATIOnS AND CREDITS Figure 1 Dr Gro Brundtland, Director-General, WHO, 1998 6 to 2003. Reproduced by permission of WHO. Figure 2 Article 19 of the WHO constitution. Reproduced 11 by permission of WHO. Figure 3 Dr Ruth Roemer (1916–2005) and Dr Judith Mackay, WHA, May 2003. Provided by and 22 reproduced by permission of Dr Judith Mackay. Figure 4 Orchid award and Dirty Ashtray award from the FCA’s Alliance Bulletin, 2000. Reproduced by 42 permission of FCA. Figure 5 WHO FCTC history, published on 26 February 2010, the fifth anniversary of the Framework 49 Convention. Reproduced by permission of WHO. Figure 6 Death clock displayed at pre-INB-6 sessions, Geneva, February 2003. Provided by and 58 reproduced by permission of Dr Judith Mackay. Figure 7 The first session of the Conference of the Parties following the FCTC coming into force, 17 February 2006. Provided by and reproduced by permission 59 of WHO. table 1 Outline programme for ‘WHO Framework 7 Convention on Tobacco Control’ Witness Seminar table 2 Health and global change in the 1900s. Adapted 14 from Yach and Bettcher (1998): 737. table 3 Big six tobacco companies, details from company 17 websites, 14 February 2012. v table 4 Global cigarette market share, per cent of total number of cigarettes produced, 2000 and 2008. 26 Provided by Dr Judith Mackay. table 5 Recipients of FCA awards by Framework Convention Alliance Bulletin, Issues 1–45, 1999–2003, adapted from Mamudu and Glantz 43 (2009): 158. vi abbreviatiOnS ACS American Cancer Society AFRO Regional Office for Africa, WHO ASEAN Association of Southeast Asian Nations BAT British American Tobacco CARICOM Countries of the Caribbean Community CCLAT Convention-cadre pour la lutte antitabac (French, FCTC) CICG Centre International de Conférences Genève, Geneva, Switzerland COP-n Conference of the Parties, the governing body of the FCTC made up of all Parties to the FCTC. DG Director-General EC European Community ECOSOC Economic and Social Council, UN EMRO Regional Office for the Eastern Mediterranean, WHO EURO Regional Office for Europe, WHO FAO Food and Agriculture Organization of the United Nations FCA Framework Convention Alliance FCTC Framework Convention on Tobacco Control, WHO GATT General Agreement on Tariffs and Trade, Geneva (the World Trade Organization from 1994) IMF International Monetary Fund INB-n Intergovernmental Negotiating Body for FCTC, six bodies met, 2000–03 Infact Infant Formula Action Coalition (1977–84), Infact (1984–2004), Corporate Accountability International (2004– ) vii INFOTAB A conglomeration of all the tobacco companies in the UK (Tobacco Documentation Centre from 1992), Brentford, Middx ITGA International Tobacco Growers Association, formed in 1984 by growers’ organizations from Argentina, Brazil, Canada, Malawi, United States and Zimbabwe, of which only Brazil and Canada have ratified the FCTC NATT Network for Accountability of Tobacco Transnationals includes 75 NGOs from 50 countries NGO Non-governmental organization PAHO Pan-American Health Organization, WHO SEARO Regional Office for South East Asia, WHO STAT Stop Teenage Addiction to Tobacco TFI Tobacco Free Initiative, WHO TobReg WHO Study Group on Tobacco Product Regulation UNCTAD UN Conference on Trade and Development UNDCP UN Office on Drugs and Crime UNICEF UN Children’s Fund VCLT Vienna Convention on the ‘law of treaties’ WHA World Health Assembly WHO World Health Organization WTO World Trade Organization viii WITNESS SEMINARS: MEETINGS AND PUBLICATIONS 1 In 1990 the Wellcome Trust created a History of Twentieth Century Medicine Group, associated with the Academic Unit of the Wellcome Institute for the History of Medicine, to bring together clinicians, scientists, historians and others interested in contemporary medical history. Among a number of other initiatives the format of Witness Seminars, used by the Institute of Contemporary British History to address issues of recent political history, was adopted, to promote interaction between these different groups, to emphasize the potential benefits of working jointly, and to encourage the creation and deposit of archival sources for present and future use. In June 1999 the Governors of the Wellcome Trust decided that it would be appropriate for the Academic Unit to enjoy a more formal academic affiliation and turned the Unit into the Wellcome Trust Centre for the History of Medicine at UCL from 1 October 2000 to 30 September 2010. The History of Twentieth Century Medicine Group has been part of the School of History, Queen Mary, University of London, since October 2010, as the History of Modern Biomedicine Research Group, which the Wellcome Trust continues to fund. The Witness Seminar is a particularly specialized form of oral history, where several people associated with a particular set of circumstances or events are invited to come together to discuss, debate, and agree or disagree about their memories. To date, the History of Twentieth Century Medicine Group has held more than 50 meetings, most of which have been published, as listed on pages pages xiii–xvii. Subjects are usually proposed by, or through, members of the Programme Committee of the Group, which includes professional historians of medicine, practising scientists and clinicians, and once an appropriate topic has been agreed, suitable participants are identified and invited. This inevitably leads to further contacts, and more suggestions of people to invite. As the organization of the meeting progresses, a flexible outline plan for the meeting is devised, usually with assistance from the meeting’s chairman, and some participants are invited to ‘set the ball rolling’ on particular themes, by speaking for a short period to initiate and stimulate further discussion. 1 The following text also appears in the ‘Introduction’ to recent volumes of Wellcome Witnesses to Twentieth Century Medicine as listed on pages xiii–xvii. ix Each meeting is fully recorded, the tapes are transcribed and the unedited transcript is immediately sent to every participant. Each is asked to check his or her own contributions and to provide brief biographical details. The editors turn the transcript into readable text, and participants’ minor corrections and comments are incorporated into that text, while biographical and bibliographical details are added as footnotes, as are more substantial comments and additional material provided by participants. The final scripts are then sent to every contributor, accompanied by forms assigning copyright to the Wellcome Trust. Copies of all additional correspondence received during the editorial process are deposited with the records of each meeting in archives and manuscripts, Wellcome Library, London. As with all our meetings, we hope that even if the precise details of some of the technical sections are not clear to the non-specialist, the sense and significance of the events will be understandable. Our aim is for the volumes that emerge from these meetings to inform those with a general interest in the history of modern medicine and medical science; to provide historians with new insights, fresh material for study, and further themes for research; and to emphasize to the participants that events of the recent past, of their own working lives, are of proper and necessary concern to historians. x AcknowledgementS WHO FCTC was suggested as a suitable topic for a Witness Seminar by Dr Sanjoy Bhattacharya, who assisted us in planning the meeting. We are very grateful to him and to Dr Faith McLellan for her excellent moderating of the occasion. We are particularly grateful to Professor Virginia Berridge for writing the Introduction to the published proceedings. We thank Dr Judith Mackay, Dr Hoomen Momen of the the Department of Knowledge Management and Sharing and co-ordinator of WHO press and Dr Doug Bettcher, WHO TFI, for their help with the photographs; and Professor Richard Ashcroft for reading the final draft. For permission to reproduce images included here, we thank the World Health Organization. Additionally, we would like to thank Ms Marine Perraudin and Dr Hooman Momen of the Department of Knowledge Management and Sharing at the Geneva headquarters of WHO for their help with the meeting. As with all our meetings, we depended a great deal on the audiovisual department, catering, reception, and security at the Geneva headquarters of WHO to ensure its smooth running; Mr Akio Morishima has supervised the design and production of this volume; we thank our indexer, Ms Liza Furnival, and our readers, Mrs Sarah Beanland, Ms Fiona Plowman and Mr Simon Reynolds.
Recommended publications
  • Tabak Und Zigaretten Der Vegan News-‐Einkaufsguide
    Tabak und Zigaretten Der Vegan News-Einkaufsguide VEGAN* Imperial Tobacco Quelle: www.imperial-tobacco.at/component/itrfile/?view=download&id=209 Davidoff JPS Drum R1 Ernte 23 Rizla Gauloises Route 66 Gauloises Brunes Stuyvesant Gitanes Van Nelle Golden Virginia West Von-Eicken Quelle: http://www.von-eicken.com/de/umweltschutz/ Allure Dockers Burton Manitou Organic Denim Pepe Dimitrinos St. Pauli Pöschl Tabak Quelle: E-Mail Anfrage Black Hawk Manila Bounty Pontiac Brookfield Pueblo Holland Art Red Bull JBR Turner *Vegan in Zusammenhang mit Zigaretten/Tabak meint an dieser Stelle, dass in den Produkten keine tierischen Inhaltsstoffe vorhanden sind sowie seitens des Unternehmens keine TierversuChe durChgeführt werden. Vegan News Stand: 31. Dezember 2015 NICHT FÜR VEGANER GEEIGNET Lorillard Tobacco Kent Old Gold Maverick Satin Max True Newport R.J. Reynolds Tobacco Company Barclay Monarch Belair More Capri Natural American Spirit Carlton Now Doral Salem Eclipse Tareyton GPC Vantage Kool Viceroy Misty Philip Morris Accord Diana Number 7 Alpine Dji Sam Soe Optima Apollo-Soyuz Eve Papastratos Assos English Ovals Parisienne Jaune Basic f6 Parliament Belmont Fajrant Peter Jackson Best Fortune Petra Bond Street Hope Philip Morris Boston Juwel Players Bristol Karo Polyot Bucks L&M Red & White Cambridge Lark Sampoerna A Canadian Classics Longbeach Saratoga Chesterfield Marlboro SG Classic Merit Sparta Collector’s Choice Moven Gold Start Commander Multi DeLuxe U Mild Daves Multifilter Vatra Delicados Muratti Virginia Slims Vegan News Stand: 31. Dezember 2015 British American Tobacco Dunhill Prince Fair Play Samson HB Schwarzer Krauser Javaanse Jongens Vogue Lord Vype (E-Zigarette) Lucky Strike Westpoint Pall Mall Japan Tobacco International Benson & Hedges Nil Camel Old Holborn Club Overstolz Coronas Peter I Ducat Reyno Export 'A' Ronson Glamour Russian Style M Salem Magna Silk Cut Mayfair Sobranie Memphis Sovereign Mi Ne St George Mild Seven Tawa Mercedes de Luxe Troika Monte Carlo Winston More Winchester Vegan News Stand: 31.
    [Show full text]
  • Sep 19 New Tobacco Products.Ppt
    9/20/13 New Products Old Tricks The Problem What’s the Problem with New Products? New tobacco products are designed to: – Draw in new and youth users – Keep smokers smoking – Circumvent regulations and taxation 1 9/20/13 Increased youth smokeless tobacco use TOLL OF OTHER TOBACCO USE National Youth Smoking and Smokeless Tobacco Use 1997 - 2011 2003-2009: -11.0% 2003-2011: -17.4% 2003-2009: -9.2% 2003-2011: -8.7% 2003-2009: +36.4% 2003-2011: +16.4% 2003-2009: +32.8% 2003-2011: +14.9% Source: CDC, Youth Risk Behavior Surveillance Survey. 2 9/20/13 Most popular snuff brands among 12-17 year olds 1999-2011 2011 Top 3 Most Popular Moist Snuff Brands among 12-17 year olds 1. Grizzly (Reynolds American, via American Snuff Company) 2. Skoal (Altria, via UST) 3. Copenhagen (Altria, via UST) Source: 2011 NSDUH Source: Analysis of NHSDA, NSDUH data Health Harms of Other Tobacco Use Smokeless Tobacco It [smokeless • Cancer, including oral cancer tobacco] is not a safe and pancreatic cancer substitute for smoking cigarettes. • Gum disease -- U.S. Surgeon General, 1986 • Nicotine addiction Cigar Use • Cancer of the oral cavity, larynx, esophagus and lung 3 9/20/13 Brand development, Acquisitions Over Time WHERE IS THE INDUSTRY HEADED? Companies under in 1989 ( ) 4 9/20/13 Companies under in 2013 (28.5% economic interest) Tobacco Brands in 2013 Non-Tobacco Products 5 9/20/13 Companies under RJR Nabisco in 1989 Companies under in 2013 (formerly Conwood Company) B&W no longer exists as a separate company.
    [Show full text]
  • Supplementary Table 10.7
    Factory-made cigarettes and roll-your-own tobacco products available for sale in January 2019 at major Australian retailers1 Market Pack Number of Year Tobacco Company segment2 Brand size3 variants Variant name(s) Cigarette type introduced4 British American Super-value Rothmans5 20 3 Blue, Gold, Red Regular 2015 Tobacco Australia FMCs 23 2 Blue, Gold Regular 2018 25 5 Blue, Gold, Red, Silver, Menthol Green Regular 2014 30 3 Blue, Gold, Red Regular 2016 40 6 Blue, Gold, Red, Silver, Menthol Green, Black6 Regular 2014 50 5 Blue, Gold, Red, Silver, Menthol Green Regular 2016 Rothmans Cool Crush 20 3 Blue, Gold, Red Flavour capsule 2017 Rothmans Superkings 20 3 Blue, Red, Menthol Green Extra-long sticks 2015 ShuangXi7 20 2 Original Red, Blue8 Regular Pre-2012 Value FMCs Holiday 20 3 Blue, Gold, Red Regular 20189 22 5 Blue, Gold, Red, Grey, Sea Green Regular Pre-2012 50 5 Blue, Gold, Red, Grey, Sea Green Regular Pre-2012 Pall Mall 20 4 Rich Blue, Ultimate Purple, Black10, Amber Regular Pre-2012 40 3 Rich Blue, Ultimate Purple, Black11 Regular Pre-2012 Pall Mall Slims 23 5 Blue, Amber, Silver, Purple, Menthol Short, slim sticks Pre-2012 Mainstream Winfield 20 6 Blue, Gold, Sky Blue, Red, Grey, White Regular Pre-2012 FMCs 25 6 Blue, Gold, Sky Blue, Red, Grey, White Regular Pre-2012 30 5 Blue, Gold, Sky Blue, Red, Grey Regular 2014 40 3 Blue, Gold, Menthol Fresh Regular 2017 Winfield Jets 23 2 Blue, Gold Slim sticks 2014 Winfield Optimum 23 1 Wild Mist Charcoal filter 2018 25 3 Gold, Night, Sky Charcoal filter Pre-2012 Winfield Optimum Crush 20
    [Show full text]
  • Where Have All the Fairies Gone? Gwyneth Evans
    Volume 22 | Number 1 | Issue 83, Autumn Article 4 10-15-1997 Where Have All the Fairies Gone? Gwyneth Evans Follow this and additional works at: https://dc.swosu.edu/mythlore Recommended Citation Evans, Gwyneth (1997) "Where Have All the Fairies Gone?," Mythlore: A Journal of J.R.R. Tolkien, C.S. Lewis, Charles Williams, and Mythopoeic Literature: Vol. 22 : No. 1 , Article 4. Available at: https://dc.swosu.edu/mythlore/vol22/iss1/4 This Article is brought to you for free and open access by the Mythopoeic Society at SWOSU Digital Commons. It has been accepted for inclusion in Mythlore: A Journal of J.R.R. Tolkien, C.S. Lewis, Charles Williams, and Mythopoeic Literature by an authorized editor of SWOSU Digital Commons. An ADA compliant document is available upon request. For more information, please contact [email protected]. Where Have All the Fairies Gone? Abstract Examines a number of modern fantasy novels and other works which portray fairies, particularly in opposition to Victorian and Edwardian portrayals of fairies. Distinguishes between “neo-Victorian” and “ecological” fairies. Additional Keywords Byatt, A.S. Possession; Crowley, John. Little, Big; Fairies in literature; Fairies in motion pictures; Jones, Terry. Lady Cottington’s Pressed Fairy Book; Nature in literature; Wilson, A.N. Who Was Oswald Fish? This article is available in Mythlore: A Journal of J.R.R. Tolkien, C.S. Lewis, Charles Williams, and Mythopoeic Literature: https://dc.swosu.edu/mythlore/vol22/iss1/4 P a g e 12 I s s u e 8 3 A u t u m n 1 9 9 7 M y t h l o r e W here Have All the Fairies Gone? G wyneth Evans As we create gods — and goddesses — in our own Crowley's Little, Big present, in their very different ways, image, so we do the fairies: the shape and character a contrast and comparison between imagined characters an age attributes to its fairies tells us something about the of a Victorian and/or Edwardian past and contemporary preconceptions, taboos, longings and anxieties of that age.
    [Show full text]
  • ASH NEW ZEALAND Tobacco Returns Analysis 2013 1 TOBACCO
    ASH NEW ZEALAND Tobacco Returns Analysis 2013 TOBACCO RETURNS ANALYSIS 2013 Tobacco manufacturers and importers in New Zealand are required to file their annual tobacco returns pursuant to section 35 of the Smokefree Environments Act 1990. The tobacco returns consist of two components – Schedule A and Schedule B. Schedule A is the information about ingredients and amounts used in their tobacco products. Schedule B is the company list of all their products, retail price and sale quantity We analysed data from Schedule B in order to understand the brand positioning of the major tobacco companies. This includes analysis of retail price, sale volume and estimated sales returned of all tobacco brands. Market share also is estimated based on this data. This analysis accounted for cigarette and loose leaf tobacco products sold within New Zealand (or domestic market). Information provided by tobacco companies may vary and hence the results of the analysis. British American Tobacco New Zealand (BATNZ) provided recommended retail prices as at January 2013 while Imperial Tobacco New Zealand and Philip Morris provided theirs as at December 2013. This had resulted in artificially higher estimates of average retail price and sale return for BATNZ products due to the January 2014 tax increase. Having considered this, most of the results on overall tobacco market in this analysis were presented according to the sale quantity and hence better accuracy. Fourteen companies filed their tobacco returns in 2013. As this analysis only included cigarette and loose leaf tobacco products, three companies were excluded as they sold cigar or other tobacco products. Tobacco Returns 2012 can be accessed through the National Drug Policy New Zealand website (http://www.ndp.govt.nz/moh.nsf/indexcm/ndp-tobacco-returns-2012 ).
    [Show full text]
  • How Western Invests in Arms, Tobacco and Oil Companies
    Equities RBC Wealth Management defines equities as pieces of a company, also known as "stocks." When you buy stocks or shares of a company, you're basically purchasing an ownership interest in that company. A company's stockholders or shareholders all have equity in the company, or own a fractional portion of the whole company. Western’s U.S. equities Western’s U.S. equities are managed by State Street Global Advisors and J.P. Morgan Asset Management. The SSGA man- ages large cap U.S. equities and tries to match the S&P 500 index. It also manages U.S. mid cap equities and tries to match the S&P mid cap 400. International Equities Western’s international equities are managed by Franklin Tem- pleton Institutional and MFS Investment management. Tem- pleton manages international equities with a bottom-up value process. MFS manages international equities with a bot- tom-up “growth-at-a-reasonable price” (GARP) process. Market capitalization Market capitalization is the total dollar market value of all of a company's outstanding shares. Market capitalization is cal- culated by multiplying a company's shares outstanding by the current market price of one share. The investment community uses this figure to determine a company's size, as opposed to sales or total asset figures. (Source: Investopedia) S&P 500: Unadjusted company market capitalization of US $5.3 billion or more. S&P MidCap 400: Unadjusted company market capitalization of US $1.4 billion to US $5.9 billion. Equity investments, which account or 65.8 per cent o Western’s total operating and endowment portolio, are managed by third party investment companies and Western does not have direct control over these investments.
    [Show full text]
  • Altria Group, Inc. Annual Report
    ananan Altria Altria Altria Company Company Company an Altria Company ananan Altria Altria Altria Company Company Company | Inc. Altria Group, Report 2020 Annual an Altria Company From tobacco company To tobacco harm reduction company ananan Altria Altria Altria Company Company Company an Altria Company ananan Altria Altria Altria Company Company Company an Altria Company Altria Group, Inc. Altria Group, Inc. | 6601 W. Broad Street | Richmond, VA 23230-1723 | altria.com 2020 Annual Report Altria 2020 Annual Report | Andra Design Studio | Tuesday, February 2, 2021 9:00am Altria 2020 Annual Report | Andra Design Studio | Tuesday, February 2, 2021 9:00am Dear Fellow Shareholders March 11, 2021 Altria delivered outstanding results in 2020 and made steady progress toward our 10-Year Vision (Vision) despite the many challenges we faced. Our tobacco businesses were resilient and our employees rose to the challenge together to navigate the COVID-19 pandemic, political and social unrest, and an uncertain economic outlook. Altria’s full-year adjusted diluted earnings per share (EPS) grew 3.6% driven primarily by strong performance of our tobacco businesses, and we increased our dividend for the 55th time in 51 years. Moving Beyond Smoking: Progress Toward Our 10-Year Vision Building on our long history of industry leadership, our Vision is to responsibly lead the transition of adult smokers to a non-combustible future. Altria is Moving Beyond Smoking and leading the way by taking actions to transition millions to potentially less harmful choices — a substantial opportunity for adult tobacco consumers 21+, Altria’s businesses, and society. To achieve our Vision, we are building a deep understanding of evolving adult tobacco consumer preferences, expanding awareness and availability of our non-combustible portfolio, and, when authorized by FDA, educating adult smokers about the benefits of switching to alternative products.
    [Show full text]
  • Tobacco Product Use and Associated Factors Among Middle and High School Students — United States, 2019
    Morbidity and Mortality Weekly Report Surveillance Summaries / Vol. 68 / No. 12 December 6, 2019 Tobacco Product Use and Associated Factors Among Middle and High School Students — United States, 2019 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Surveillance Summaries CONTENTS Introduction ............................................................................................................2 Methods ....................................................................................................................2 Results .......................................................................................................................5 Discussion ................................................................................................................8 Limitations ...............................................................................................................9 Conclusion ............................................................................................................ 10 References ............................................................................................................. 10 The MMWR series of publications is published by the Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, GA 30329-4027. Suggested citation: [Author names; first three, then et al., if more than six.] [Title]. MMWR Surveill Summ 2019;68(No. SS-#):[inclusive
    [Show full text]
  • PMI Powerpoint Presentation
    Investor Day – Asia Region Lausanne, June 23, 2010 Matteo Pellegrini President, Asia Region Philip Morris International Agenda ● Operating environment ● PMI strategic priorities in Asia ● Brand portfolio and innovations ● Key Asia markets: highlights ● Questions & Answers 2 Operating Environment 2009 • Population : 3.8 billion Korea Japan • Cigarette Volume: 3.4 trillion China Taiwan Cigarette Volume: Pakistan Hong Kong 1.2 trillion units (Excl. – China) Others 15% India Bangladesh Indonesia Thailand Philippines 22% Vietnam Bangladesh 6% Malaysia Pakistan Singapore 6% Vietnam Indonesia 7% Japan 20% Australia Philippines New Zealand 7% Korea 8% India Asia accounts for 56% of the world’s population 9% And 60% of the world’s cigarette volume… Note: Cigarette volumes reflect 2009 Source: Global Insights 3 GDP Per Capita in 15 Key Markets ($ 000) 50 43.9 39.9 36.4 30.4 USA US $ 46,300 European Union US $ 33,100 Asia Pacific US $ 4,000 17.2 16.5 7.0 Asia: $ 4.0 3.9 3.5 2.3 1.8 1.1 1.0 0.9 0.6 0 India China Japan Taiwan Vietnam Thailand Pakistan Malaysia Australia Indonesia Singapore Philippines Hong Kong Bangladesh South Korea Source: Global Insights 4 GDP Growth and Unemployment Rates (%) Japan (%) Australia 7 7 7 7 5.1 4.7 4.1 5.6 3.8 4.0 5.2 4.8 4.4 2.0 2.3 2.0 4.2 2008 2009 4.7 3.3 0 0 2.6 2006 2007 2010 F 2.4 (1.2) 1.3 (5.2) (7) (7) 0 0 GDP Growth Rate 2006 2007 2008 2009 2010 F Unemployment Rate (%) Indonesia (%) Philippines 12 12 12 12 10.3 9.1 8.4 7.9 8.1 8.0 7.3 7.4 7.5 7.3 6.3 6.1 5.5 5.6 5.3 7.1 4.5 3.8 4.2 0.9 0 0 0 0 2006 2007 2008
    [Show full text]
  • Tobacco, E-Cigarettes and Alternative Products
    Tobacco, E-Cigarettes and Alternative Products: Product Guide FOR PEDIATRIC PROVIDERS Although youth use of traditional cigarettes has declined in New York City (NYC), youth have turned to other products, including cigars, smokeless tobacco, and electronic cigarettes (e-cigarettes). These products are often flavored (such as with menthol) and almost always contain nicotine. Flavors are concerning because they can mask the harshness of tobacco, appeal to kids, and are often directly marketed to teens and preteens. NICOTINE can change the chemistry of the adolescent brain. It may affect learning ability and worsen memory and concentration. Youth are particularly vulnerable to nicotine dependence, which can occur even with occasional use. Nicotine may also affect the way the adolescent brain processes other drugs, like alcohol, cannabis and cocaine. The following is a list of selected products with their negative health effects to help you better counsel and guide your patients and their families. 2 TOBACCO: Smokeless Tobacco THE FACTS • Smokeless tobacco is not burned or smoked but always contains nicotine.* V It includes tobacco that can be sucked, chewed, spit or swallowed, depending on the product. PRODUCT NAME WHAT IT IS Chewing • Comes in loose leaf, plug or twist form Tobacco V Used by taking a piece and placing it between the cheek and gums; Also Known As may require spitting. Chew Snuff • Comes in moist, dry or packet (snus) form Also Known As V Moist snuff is used by taking a pinch and placing it between the lip Dip or cheek and gums; requires spitting. V Dry snuff is used by putting a pinch of powder in the mouth or by sniffing into the nose.
    [Show full text]
  • Creating a Smoke-Free Home
    Creating a smoke-free home REFRESH How to Guide for Professionals Working with Families and Children SECTION 1 Introduction Page 3 SECTION 2 Who should use this guide? Page 4 SECTION 3 Why should you use this guide? Page 4 SECTION 4 How to use this guide Page 4 SECTION 5 What does the evidence say? Page 5 5.1 What is second-hand smoke? Page 5 5.2 Is smoking in the home and car common? Page 5 5.3 What do we know about exposure levels in the home and car? Page 5 5.4 Key facts on second-hand smoke and effects on children’s health Page 7 5.5 Tobacco smoke and house fires Page 7 SECTION 6 Common beliefs around second-hand smoke exposure Page 8 SECTION 7 The benefits of having a completely smoke-free home and car Page 10 SECTION 8 Hints and tips for parents on creating a smoke-free home and car Page 11 SECTION 9 Toxic breakdown of a cigarette Page 12 RAISING THE ISSUE - GUIDANCE FOR PROFESSIONALS Acknowledgements: SECTION 10 Practical tips on raising the issue and encouraging change Page 13 NHS Health Scotland Second-hand 10.1 The ‘REFRESH’ Flowchart Page 14 Smoke Coordinators Network NHS Rotherham SECTION 11 Raising the issue of second-hand smoke exposure in the home Page 15 Northfield Mother and Toddler 11.1 Overcoming parent barriers to creating a smoke-free home and car Page 15 Group, Aberdeen 11.2 Overcoming practitioner barriers to raising the issue with parents/carers Page 18 Gwen Russell Lorna McKenzie SECTION 12 Additional information on smoke-free homes Page 20 Kim Brannigan Lesley Young SECTION 13 Further support Page 20 SECTION 14 Further information……………………………………22 Page 20 For additional information on SECTION 15 REFRESH, please visit References Page 21 http//www.refreshproject.org.uk Getting started 1.
    [Show full text]
  • Alaska Native Adult Tobacco Survey Member List Version
    APPENDIX K: SURVEY (MEMBER LIST VERSION) |___|___|___|___| |___| |___|___| |___|___|___|___| |___|___|___|___| Year Interview Interviewer Survey Number Respondent ID Supervisor Alaska Native Adult Tobacco Survey Member List Version TABLE OF CONTENTS Section Page 1. Introduction ............................................................................................. 2 2. General Health .......................................................................................... 5 3. Cigarette Use ............................................................................................ 5 4. Iqmik Use ............................................................................................... 14 5. Chewing Tobacco (Spit) .......................................................................... 23 6. Snuff or Dip Tobacco .............................................................................. 32 7. Secondhand Smoke Exposure ................................................................. 42 8. Risk Perception ...................................................................................... 44 9. Demographics......................................................................................... 48 10. User-Selected Items ............................................................................. 52 Public burden of this collection of information is estimated to average 40 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed,
    [Show full text]